Formulating, a key part of the pharmaceutical value chain, is a ‘make or break’ step in developing an active pharmaceutical ingredient (API) into a viable product. Formulators actively research, design, and iterate formulations that ensure the stability and efficacy of APIs, improve patient compliance with treatment regimen, and adhere to changing regulatory requirements. Without a strategic and intelligent formulating process, an API would never make it into the market.
Here, we discuss how pharmaceutical companies can maximize the strategic value of formulations data to shorten development timelines, stay ahead of competition and position themselves for success. Providing formulators with accurate and well-curated information can enable them to focus on innovating new formulation designs rather than spending time on repetitive, tedious activities.
https://www.cas.org/resources/whitepapers/formulations-data-value
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory